RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GenMont Biotech Stock

GenMont Biotech P/E 2024

GenMont Biotech P/E

68.23

Ticker

3164.TW

ISIN

TW0003164000

As of Sep 29, 2024, GenMont Biotech's P/E ratio was 68.23, a 79.46% change from the 38.02 P/E ratio recorded in the previous year.

The GenMont Biotech P/E history

GenMont Biotech Aktienanalyse

What does GenMont Biotech do?

GenMont Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering GenMont Biotech's P/E Ratio

The Price to Earnings (P/E) Ratio of GenMont Biotech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing GenMont Biotech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of GenMont Biotech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in GenMont Biotech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about GenMont Biotech stock

What is the price-to-earnings ratio of GenMont Biotech?

The price-earnings ratio of GenMont Biotech is currently 68.23.

How has the price-earnings ratio of GenMont Biotech changed compared to last year?

The price-to-earnings ratio of GenMont Biotech has increased by 79.46% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of GenMont Biotech high compared to other companies?

Yes, the price-to-earnings ratio of GenMont Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of GenMont Biotech affect the company?

An increase in the price-earnings ratio of GenMont Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of GenMont Biotech affect the company?

A decrease in the price-earnings ratio of GenMont Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of GenMont Biotech?

Some factors that influence the price-earnings ratio of GenMont Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does GenMont Biotech pay?

Over the past 12 months, GenMont Biotech paid a dividend of 0.7 TWD . This corresponds to a dividend yield of about 3.06 %. For the coming 12 months, GenMont Biotech is expected to pay a dividend of 0.7 TWD.

What is the dividend yield of GenMont Biotech?

The current dividend yield of GenMont Biotech is 3.06 %.

When does GenMont Biotech pay dividends?

GenMont Biotech pays a quarterly dividend. This is distributed in the months of September, September, July, July.

How secure is the dividend of GenMont Biotech?

GenMont Biotech paid dividends every year for the past 1 years.

What is the dividend of GenMont Biotech?

For the upcoming 12 months, dividends amounting to 0.7 TWD are expected. This corresponds to a dividend yield of 3.06 %.

In which sector is GenMont Biotech located?

GenMont Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von GenMont Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GenMont Biotech from 7/10/2024 amounting to 0.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did GenMont Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of GenMont Biotech in the year 2023?

In the year 2023, GenMont Biotech distributed 0.57 TWD as dividends.

In which currency does GenMont Biotech pay out the dividend?

The dividends of GenMont Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von GenMont Biotech

Our stock analysis for GenMont Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GenMont Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.